Details of the Drug

General Information of Drug (ID: DMI0GZT)

• Drug Name: MAGE-A3 immunotherapeutic

Indication

Disease Entry	ICD 11	Status	REF
Melanoma	2C30	Phase 3	[1]
Non-small-cell lung cancer	2C25.Y	Phase 3	[1]
Type-2 diabetes	5A11	Phase 3	[1]

• Cross-matching ID: TTD ID: D02MPT
• Repurposed Drugs (RPD): Click to Jump to the Detailed RPD Information of This Drug

References

• [1] Clinical pipeline report, company report or official report of GlaxoSmithKline.